公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)! YZ剂描述: 产品名称:Ibiglustat L-Malic acid 产品别名:见爱必信官网 英文别名:Ibiglustat L-Malic acid 靶点:Glucosylceramide synthase. CAS:1629063-78-0 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:Ibiglustat L-Malic acid (Venglustat L-Malic acid), a potential therapy for PD Parkinson’s disease, SRT in Fabry’s and Gaucher’s, is a selective, allosteric inhibitor of glucosylceramide synthase (GCS) with ability to cross the blood-brain barrier. 溶解性: In Vitro: DMSO : ≥ 102 mg/mL (194.82 mM) * "≥" means soluble, but saturation unknown. Preparing Stock Solutions ConcentrationSolventMass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.9100 mL | 9.5498 mL | 19.0996 mL | 5 mM | 0.3820 mL | 1.9100 mL | 3.8199 mL | 10 mM | 0.1910 mL | 0.9550 mL | 1.9100 mL |
*请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存方式和期限。 体外研究: Ibiglustat (SAR402671) (1 μM, 15 days) treated FD cells are close to the physiological level in untreated WT cells in GL-3 levels, suggesting that Ibiglustat can prevent additional GL-3 accumulation and could serve to ameliorate the abundant levels of this sphingolipid in FD cardiomyocytes. 体内研究:Ibiglustat (SAR402671) (1 μM, 15 days) treated FD cells are close to the physiological level in untreated WT cells in GL-3 levels, suggesting that Ibiglustat can prevent additional GL-3 accumulation and could serve to ameliorate the abundant levels of this sphingolipid in FD cardiomyocytes. 产品信息订购: 产品货号 | 产品名称 | 规格 | 价格 | 大包装及货期 | abs821053 | Ibiglustat L-Malic acid | 2mg | 1320 | 立即咨询 | 产品更多信息请进入爱必信网站咨询 |